{
    "Trade/Device Name(s)": [
        "ForSure One Step Buprenorphine Drug Cup Test Device"
    ],
    "Submitter Information": "Tianjin New Bay Bioresearch Co., Ltd.",
    "510(k) Number": "K122064",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042990"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG"
    ],
    "Summary Letter Date": "May 7, 2013",
    "Summary Letter Received Date": "April 2, 2013",
    "Submission Date": "February 5, 2013",
    "Regulation Number(s)": [
        "21CFR862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Specimen collection cup with built-in strip holder"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Methodologies": [
        "Qualitative drug screening"
    ],
    "Submission Type(s)": [
        "Test",
        "Specimen collection device",
        "Cup",
        "Strip"
    ],
    "Document Summary": "FDA 510(k) summary for ForSure One Step Buprenorphine Drug Cup Test Device, a lateral flow immunochromatographic assay for qualitative detection of buprenorphine in human urine.",
    "Indications for Use Summary": "Qualitative detection of buprenorphine in human urine at 10 ng/mL cutoff for prescription and over-the-counter use; provides preliminary analytical test results and requires confirmatory testing for positive results.",
    "fda_folder": "Toxicology"
}